Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 205-214

  Liu, Guoqing ^a   Ashbourne Excoffon, Katherine J D ^a   Benoit, Patrick ^b   Ginzinger, David G ^a   Miao, Li ^a   Ehrenborg, Ewa ^a   Duverger, Nicolas ^b   Denefle, Patrice P ^b   Hayden, Michael R ^a   Lewis, M E Suzanne ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENZYME ANTIBODY; LIPOPROTEIN LIPASE; SODIUM CHLORIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPRESSION VECTOR; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE CASSETTE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; LIPOPROTEIN METABOLISM; NONHUMAN; ROUS SARCOMA ONCOVIRUS;

EID: 16944362700     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-205     Document Type: Article

References (36)

1. AUWERX, J., SCHOONJANS, K., and STAHLS, B. (1995). Regulation of liver lipoprotein lipase gene expression. In Atherosclerosis X. F.P. Woodward, J. Davignon, and A. Sniderman, eds. (Elsevier Science B. V., Amsterdam) pp. 241-245.
2. BABIRAK, S.P., IVERIUS, P.H., FUJIMOTO, W.Y., and BRUNZELL, J.D. (1989). The detection and characterization of the heterozygous state for lipoprotein lipase deficiency. Arteriosclerosis 9, 326-334.
3. BENGTSSON-OLIVECRONA, G., OLIVECRONA, T., HULTIN, M., LIU, G., and VILARO, S. (1992). Uptake of lipoprotein lipase in the liver: mechanism and physiological relevance. In Hepatic Endocytosis of Lipids and Proteins. E. Winkler, eds. (W. Zuckswerdt Verlag) pp. 292-298.
4. BRAUN, E.A., and SEVERSON, D.L. (1992). Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem. J. 287, 337-347.
5. BRUNZELL, J.D. (1995). Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In Metabolic Basis of Inherited Disease, 7th ed. C.R. Scriver, A.L. Beaudet, D. Sly, and D. Valle eds. (McGraw-Hill Book Co., New York) pp. 1913-1932.
6. CHAN, L. (1995). Use of somatic gene transfer to study lipoprotein metabolism in experimental animals in vivo. Curr. Opin. Lipidol. 6, 335-340.
7. CHENG, L., ZIEGELHOFFER, P.R., and YANG, N-S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
8. CHROMCZYNSKI, P., and SACCHI, N. (1983). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 132, 6-13.
9. COTTEN, M., BAKER, A., SALTIK, M., WAGNER, E., and BUSCHLE, M. (1994). Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther. 1, 239-246.
10. ECKEL, R.H. (1989). Lipoprotein lipase: A multi-functional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320, 1060-1068.
11. EVANS, A.J., SAWYEZ, C.G., WOLFE, B.M., and HUFF, M.W. (1992). Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. J. Biol. Chem. 267, 10743-10751.
12. GAGNE, C., BRUN, L.D., JULIEN, P., MOORJANI, S., and LUPIEN, P.J. (1989). Primary lipoprotein lipase activity deficiency: clinical investigation of a French Canadian population. Canadian Med. Assoc. J. 140, 405-411.
13. GAGNE, E., GENEST, J., JR., ZHANG, H., CLARKE, L.A., and HAYDEN, M.R. (1994). Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler. Thromb. 14, 1250-1257.
14. GORMAN, C.M., MERLINO, G.T., WILLINGHAM, M.C., PASTAN, I., and HOWARD, B.H. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci USA 79, 6777-6781.
15. IVERIUS, P.H., and BRUNZELL, J.D. (1985). Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am. J. Physiol. 249, E107-E114.
16. IVERIUS, P.H., and OSTLUND-LINDQVIST, A.M. (1986). Preparation, characterization and measurement of lipoprotein lipase. Methods Enzymol. 129, 691-704.
17. JAFFE, H.A., DANIEL, C., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., and PERRICAUDET, M. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
18. JAVITT, N.B. (1990). HepG2 cells as a resource for metabolic studies: Lipoprotein, cholesterol and bile acids. FASEB J. 4, 161-168.
19. KNOWLES, B.B., HOWE, C.C., and ADEN, D.P. (1980). Human hepatocellular carcinoma cell lines secrete the major plasma protein and hepatitis B surface antigen. Science 209, 497-499.
20. LEVRERO, M., BARBAN, V., MANTECA, S., BALLEY, A., BALSAMO, C., AVANTAGGIATI M.L., NATOLI, G., SKELLEKENS, H., TIOLLAIS, P., and PERRICAUDET, M. (1991). Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene 101, 195-202.
21. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
22. LOMBARDI, P., MULDER, M., VAN DER BOOM, H., FRANTS, R.R., and HAVEKES, L.M. (1993). Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. J. Biol. Chem. 268, 26113-9.
23. MIESENBOCK, G., HOLZL, B., FOGER, B., GRANDSTATTER, E., PAULWEBER, B., SANDHOFER, F., and PATSCH, J.R. (1993). Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J. Clin. Invest. 91, 448-455.
24. MULLIGAN, R.C., and BERG, P. (1980). Expression of a bacterial gene in mammalian cells. Science 209, 1422-1427.
25. NILSSON-EHLE, P., and SCHOTZ, M.C. (1976). A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17, 536-541.
26. OLIVECRONA, T., CHERNICK, S.S., BENGTSSON-OLIVECRONA, G., GARRISON, M., and SCOW, R.O. (1987). Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes: Demonstration of inactive forms of lipase in cells J. Biol. Chem. 262, 10748-10759.
27. OLIVECRONA, G., HULTIN, M., SAVONEN, R., SKOTTOVA, N., LOOKENE, A., TUGRUL, Y., and OLIVECRONA, T. (1995). Transport of lipoprotein lipase in plasma and lipoprotein metabolism. In Atherosclerosis X. F.P. Woodward, J. Davignon, and A. Sniderman, eds. (Elsevier Science B.V., Amsterdam) pp. 250-253.
28. PETERSON, J., FUJIMOTO, W.Y., and BRUNZELL, J.D. (1992). Human lipoprotein lipase: relationship of activity, heparin affinity and conformation as studied with monoclonal antibodies. J. Lipid Res. 33, 1165-1170.
29. REYMER, P.W.A., GAGNE, E., GROENEMEYER, B.E., ZHANG, H., FORSYTH, I., JANSEN, H., SEIDELL, J.C., KROMHOUT, D., LIE, K.E., KASTELEIN, J., and HAYDEN, M.R. (1995). A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 10, 28-34.
30. SKOTTOVA, N., SAVONEN, R., LOOKENE, A., HULTIN, M., and OLIVECRONA, G. (1995). Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 36, 1334-1344.
31. SPERGEL, J.M., and CHEN-KIANG, S. (1991). Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proc. Natl. Acad. Sci. USA 88, 6472-6476.
32. STRATFORD-PERRICAUDET, L.D., LEVRERO, M., CHASSE, J.F., PERRICAUDET, M., and BRIAND, P. (1990). Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1, 241-256.
33. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
34. WILLIAMS, K.J., FLESS, G.M., PETRIE, K.A., SNYDER, M.L., BROCIA, R.W., and SWENSON, T.L. (1992). Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. J. Biol. Chem. 267, 13284-13292.
35. WILSON, D.E., EMI, M., IVERIUS, P-H., HATA, A., WU, L.L., HILLAS, E., WILLIAMS, R.R., and LALOUEL, J-M. (1990). Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. Clin. Invest. 86, 735-750.
36. ZHANG, W.W., KOCH, P.E., and ROTH, J.A. (1995). Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. BioTechniques. 18, 444-447.